Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Medmen Enterprises Inc Class B Subordin CSE: MMEN-CN

Today's Change
Volume
Real-Time Last Update CSE Last Sale

Today's Trading

Day Low 0.540
Day High 0.610
Open:0.550
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
MedMen Enterprises Inc is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

No rating

Latest Press Releases

Revenues Continue to Jump for Legal Cannabis Market Expected to Exceed $73 Billion By 2027
- PR Newswire - PRF - Tue Feb 16, 6:52AM CST
PR Newswire - PRF - CMTX
Tue Feb 16, 6:52AM CST
, /PRNewswire/ -- It seems that every new report concerning future revenues for the legal cannabis market, projects higher numbers that all previous reports. What they DO agree on is that the market has had several robust years of recent growth and shows every sign that the future will continue to outperform projections. A report from Arcview predicted that global legal cannabis sales will hit by 2024, but it was quickly outpaced by a report from Grand View Research that said that the global legal marijuana market size is expected to reach by 2027, and it is anticipated to expand at a CAGR of 18.1% during the forecast period. The increasing legalization of cannabis for medical as well as adult-use is expected to promote growth.  The Grand View  said: "On the basis of type, the medical segment held the leading revenue share of 71.0% in 2019, owing to the growing adoption of cannabis as a pharmaceutical product for treating severe medical conditions, such as cancer, arthritis, and Parkinson's disease, and Alzheimer's disease among other neurological conditions. Moreover, the increasing need for pain management therapies along with the growing disease burden of chronic pain among elders is expected to boost the product demand. Based on product type, the legal marijuana buds segment accounted for the largest market share in terms of revenue... Buds are primary plant products and are readily available without any processing, which makes them relatively affordable for low-income patients. Moreover, the rapid onset of action of smoking buds compared to other types is anticipated to further fuel the segment growth."  Active Companies active today in the cannabis related markets include:  (OTCQX: INLB),  (NASDAQ: TLRY), (NASDAQ: APHA) (TSX: APHA), (OTCQX: MMNFF) (CSE: MMEN) (OTCQX: CURLF) (CSE: CURA).
Increasing Consumption, Expanding Legalization Leading to High Times for Cannabis Companies
- PR Newswire - PRF - Wed Feb 10, 7:30AM CST
PR Newswire - PRF - CMTX
Wed Feb 10, 7:30AM CST
, /PRNewswire/ -- The growth of the cannabis market over the last few years has been remarkable. The historical social negativity took a long time to overcome, but now, it has freed the markets to grow by the billions! Consumer demand has spawned revenue streams that continue to grow at a faster pace. However, some would be surprised to know that it's the medical segment… not the recreational… that is predicted to be outpace recreational marijuana in the race for revenues. One , from Market Research Future projected that the market for medical marijuana market is anticipated to acquire the market value of while thriving at a CAGR of 34% by 2023, while another from Market Data Forecast increased the projection saying that the size of the global medical cannabis market size which was projected at in 2020, is forecasted to worth by 2025, with a  CAGR of 22.9%.     Active Companies active today in the cannabis related markets include:  (NYSE: ACB) (TSX: ACB), (OTCPK: THCT),  (NASDAQ: APHA) (TSX: APHA), (NASDAQ: SNDL), (OTCQX: MMNFF) (CSE: MMEN).
BellRock Brands Executes on Growth Strategy by Expanding into Florida via MedMen Partnership
- CNW Group - Thu Dec 17, 5:00AM CST
CNW Group - CMTX
Thu Dec 17, 5:00AM CST
BellRock Brands Executes on Growth Strategy by Expanding into Florida via MedMen Partnership
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 0.190 +221.05% increase
on 02/01/21
Period Open:0.220
Price movement based on the high, low and last over the given period.
1.830 -66.67% decrease
on 02/10/21
+0.390 (+177.27%) increase
since 01/26/21
3-Month 0.150 +306.67% increase
on 12/23/20
Period Open:0.165
Price movement based on the high, low and last over the given period.
1.830 -66.67% decrease
on 02/10/21
+0.445 (+269.70%) increase
since 11/26/20
52-Week 0.140 +335.71% increase
on 10/29/20
Period Open:0.385
Price movement based on the high, low and last over the given period.
1.830 -66.67% decrease
on 02/10/21
+0.225 (+58.44%) increase
since 02/26/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies